Amanote Research
Register
Sign In
Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis
doi 10.1021/acschembio.8b00204.s002
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Analysis of Compound Weighing Precision in Drug Discovery
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Efficiency in Drug Discovery: Liver S9 Fraction Assay as a Screen for Metabolic Stability
Drug Metabolism Letters
Biochemistry
Clinical Biochemistry
Pharmacology
Pharmaceutical Science
Nontargeted Virus Sequence Discovery Pipeline and Virus Clustering for Metagenomic Data
Nature Protocols
Biochemistry
Genetics
Molecular Biology
Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery
Generating Customized Compound Libraries for Drug Discovery With Machine Intelligence
PubChem as a Public Resource for Drug Discovery
Drug Discovery Today
Drug Discovery
Pharmacology
The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
Cold Spring Harbor perspectives in medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Yeast as a Model System for Drug Discovery
Folia Pharmacologica Japonica
Pharmacology
A Network Clustering Based Feature Selection Strategy for Classifying Autism Spectrum Disorder
BMC Medical Genomics
Genetics
